CTNM EPS Estimates
Contineum Therapeutics, Inc. Class A Common Stock
$8.14
-$0.28(-3.33%)
46
Overall
60
Value
45
Tech
34
Quality
Market Cap
$306.24M
Volume
1.01M
52W Range
$8.60 - $17.79
Target Price
$21.83
CTNM EPS estimates: the consensus estimate for Contineum Therapeutics, Inc. Class A Common Stock's current fiscal year is -$1.68 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CTNM EPS Estimates
- EPS estimate, current quarter
- $-0.45
- EPS estimate, next quarter
- $-0.43
- EPS estimate, current year
- $-1.68
- EPS estimate, next year
- $-1.64
- EPS growth, 3-year
- +41.45%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.17 |
| 2024 | $-2.18 |
| 2023 | $1.36 |
| 2022 | $-10.81 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $8.14 | -3.3% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics, Inc. Class A Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW